Fundz

Satellos Bioscience reported raising $33.3 Million in an initial SEC Form D filing, from an offering of $33.3 Million

PUBLIC · MSLEMay 25, 2023

Amount Raised

$33.3 Million

$33.3 Million sold, per SEC Form D (first sale May 10, 2023)

Round Type

Venture

TorontoBiotechnology

Quick answer

Satellos Bioscience raised $33.3 Million in a funding round, dated May 10, 2023. Satellos Bioscience is based in Toronto, Ontario, Canada.

How much did Satellos Bioscience raise?
Satellos Bioscience raised $33.3 Million in a funding round on May 10, 2023.
What does Satellos Bioscience do?
Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders.
Where is Satellos Bioscience based and how big is it?
Satellos Bioscience is based in Toronto, Ontario, Canada.
Who are the decision-makers at Satellos Bioscience?
Fundz holds 1 contact at Satellos Bioscience, including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Satellos Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • S4 Medical Corp. raised $5.8M on June 23, 2023.
  • AvoMD raised $5M (Funding Round) on June 23, 2023.
  • DiaMedica Therapeutics raised $38M on June 23, 2023.
  • BioSynchronicity raised $25K (Pre-Seed) on June 23, 2023.
  • Calidi Biotherapeutics raised an undisclosed amount (Series B) on June 23, 2023.
  • Myra Vision raised $12M on June 23, 2023.

Who to call at Satellos Bioscience, and when

A new round usually means Satellos Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Satellos Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Satellos Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Satellos Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Satellos Bioscience

Location

65 FRONT STREET EAST

Toronto, Ontario, Canada

About

Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos' lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Satellos Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsFrank G., Executive Officer, Director, Promoter hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Satellos Bioscience's next move

See what Strategic adds

Satellos Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.